Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atypical Ductal Breast Hyperplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 0 results

Not applicableStudy completedNCT01975363
What this trial is testing

Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer

Who this might be right for
Atypical Ductal Breast HyperplasiaBRCA1 Gene MutationBRCA2 Gene Mutation+2 more
Ohio State University Comprehensive Cancer Center 29
Not applicableStudy completedNCT00146536
What this trial is testing

Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy

Who this might be right for
Breast Neoplasms
Dana-Farber Cancer Institute 78
Testing effectiveness (Phase 2)Looking for participantsNCT06195306
What this trial is testing

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Who this might be right for
Breast Atypical HyperplasiaBreast CarcinomaBreast Ductal Carcinoma In Situ+1 more
National Cancer Institute (NCI) 66
Not applicableLooking for participantsNCT00291096
What this trial is testing

High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer

Who this might be right for
Breast Cancer
Carol Fabian, MD 3,000
Not applicableWithdrawnNCT00329017
What this trial is testing

Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
Carol Fabian, MD
Not applicableEnded earlyNCT00794989
What this trial is testing

Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer

Who this might be right for
Breast CancerPrecancerous Condition
Roswell Park Cancer Institute 20
Early research (Phase 1)Study completedNCT00637481
What this trial is testing

A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer

Who this might be right for
Atypical Ductal Breast HyperplasiaBreast CancerDuctal Breast Carcinoma in Situ+1 more
National Cancer Institute (NCI) 66
Not applicableEnded earlyNCT03505372
What this trial is testing

Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia

Who this might be right for
Atypical Ductal Hyperplasia
Dana-Farber Cancer Institute 5
Not applicableStudy completedNCT00627276
What this trial is testing

Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia

Who this might be right for
Breast CancerPrecancerous Condition
OHSU Knight Cancer Institute 16
Not applicableUnknownNCT01034891
What this trial is testing

Women At Risk: The High Risk Breast Cancer Program

Who this might be right for
Breast Cancer
New York Presbyterian Hospital 2,000
Not applicableStudy completedNCT00291109
What this trial is testing

An Examination of Predictors of Indicators of Response to Letrozole 2.5 mg

Who this might be right for
Breast Cancer
University of Kansas 40
Not applicableStudy completedNCT01874184
What this trial is testing

Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer

Who this might be right for
Atypical Ductal Breast HyperplasiaAtypical Lobular Breast HyperplasiaBRCA1 Mutation Carrier+3 more
University of Washington 17
Not applicableStudy completedNCT01925586
What this trial is testing

Atypical Lesions of the Breast: Close Observation Versus Excision (ALCOVE)

Who this might be right for
Atypical Ductal Hyperplasia (ADH) of the Breast
Yale University 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07499999
What this trial is testing

Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer

Who this might be right for
Breast CancerDuctal CarcinomaEstrogen-receptor-positive Breast Cancer+4 more
Dana-Farber Cancer Institute 140
Not applicableStudy completedNCT00620087
What this trial is testing

Molecular Breast Imaging in Women With Atypia and LCIS

Who this might be right for
Atypical Lobular HyperplasiaAtypical Ductal HyperplasiaLobular Carcinoma in Situ
Mayo Clinic 66
Testing effectiveness (Phase 2)Looking for participantsNCT05941520
What this trial is testing

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

Who this might be right for
Breast Atypical HyperplasiaBreast CarcinomaBreast Ductal Carcinoma In Situ+1 more
National Cancer Institute (NCI) 80